Fintel reports that on February 19, 2025, Canaccord Genuity initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a ...
Fintel reports that on February 20, 2025, Canaccord Genuity initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with ...
Canaccord Genuity analyst Alexander Bedwany maintained a Buy rating on Taseko Mines (TGB – Research Report) today and set a price target of ...
Analysts at Canaccord Genuity lowered their target price on exploration and production firm Tullow Oil from 35.0p to 25.0p ...
Analysts at Canaccord Genuity reiterated their 'buy' rating on package holidays business Jet2, noting that the group has been ...
Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...
SharkNinja (NYSE:SN – Free Report) had its price target increased by Canaccord Genuity Group from $129.00 to $136.00 in a ...
Canaccord Genuity analyst Paul Buys maintained a Hold rating on HUB24 Limited (FSB – Research Report) yesterday and set a price target of ...
MP Materials Corp. (NYSE: MP) today announced that Ryan Corbett, Chief Financial Officer, will participate in the Canaccord ...
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San ...
CyberArk Software (NASDAQ:CYBR – Get Free Report) had its target price hoisted by equities research analysts at Canaccord ...
Vertex Pharmaceuticals (NASDAQ:VRTX) received an upgrade from Canaccord Genuity after the cystic fibrosis drugmaker exceeded consensus revenue estimates but missed on earnings with its Q4 2024 ...